Elizabeth Ruzzo, PhD, discusses the findings of a report published by the UNFPA, which found women were abandoning effective methods of contraception due to misinformation.
Elizabeth Ruzzo, PhD completed her graduate work at Duke University and postdoctoral research at UCLA. Throughout her 10+ year academic career in human genomics and medical genetics (where she discovered nearly 40 genetic causes for various human diseases) she repeatedly encountered knowledge gaps that hindered discovery in non-Europeans and in females. After her symptoms from birth control side effects were dismissed by medical professionals, she decided to dedicate her expertise in precision medicine to close gaps caused by historic inequity in medical research and demand a new standard of care. She founded adyn in late 2019 and was accepted into Y Combinator in the summer of 2020. She’s a recipient of Rock Health’s 2021 Top 50 in Digital Health award. Elizabeth’s work is also recognized by CB Insights which included adyn in its Digital Health 150 list, an annual ranking of the 150 most promising digital health startups in the world.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Contemporary understanding of breast cancer risk with combined oral contraceptives
April 2nd 2024Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More